microbiome-europe.com Open in urlscan Pro
5.134.13.35  Public Scan

Form analysis
1 forms found in the DOM

GET https://microbiome-europe.com/

<form role="search" method="get" id="searchform" class="searchform" action="https://microbiome-europe.com/">
  <div>
    <label class="screen-reader-text" for="s"> Search</label>
    <input type="text" value="" name="s" id="s" placeholder="">
    <input type="submit" id="searchsubmit" value="Search">
  </div>
</form>

Text Content

Skip to content


RETURNING IN 2025
NEXT EVENT IN THE SERIES IS:


THE 9TH MICROBIOME MOVEMENT DRUG DEVELOPMENT SUMMIT (US)

Menu

 * Home
 * About
   * About Event
   * Venue
   * Content Library
   * Video Library
   * Hanson Wade
 * What’s On
   * Full Event Guide
   * Expert Speakers
   * Pre-Conference Focus Day
   * Conference Day One
   * Conference Day 2
 * Partner
   * Why Partner?
   * Partnership Prospectus
   * Partners
   * Media Partners
 * Take Part
   * Pricing and Registration
   * Contact Us




THANK YOU TO OUR SPEAKERS, SPONSORS, AND DELEGATES WHO JOINED US IN JANUARY FOR
THE SUMMIT! IF YOU ARE INTERESTED IN THE 2025 EVENT, PLEASE GET IN TOUCH AT
INFO@HANSONWADE.COM.


DELIVERING CLINICAL PROOF OF CONCEPT THROUGH ADVANCED ANALYTICS & ENHANCED
PRODUCT CHARACTERISATION TO ELUCIDATE MECHANISM OF ACTION & ACHIEVE REGULATORY
APPROVAL IN EUROPE




30TH JANUARY - 1ST FEBRUARY, 2024 | BARCELONA, SPAIN

REGISTER INTEREST
EVENT GUIDE
PARTNER


WELCOME TO THE 8TH MICROBIOME MOVEMENT - DRUG DEVELOPMENT SUMMIT EUROPE

With new clinical data and more ground-breaking advancements in the technology
underpinning microbiome research, Europe’s leading microbiome organisations were
paving the way for drug development!

At the 8th Microbiome Movement - Drug Development Summit Europe where we covered
the most exciting progress in the microbiome world, from expanded analytics and
larger-scale manufacturing to the most pressing challenges from translation to
regulations. In January, 150+ microbiome innovators united in Barcelona for
the flagship meeting for European microbiome-based therapeutic developers.

We brought together microbiome trailblazers across industry, academia and
investors to share their insights across autoimmune disorders, oncology, lung
disease, hepatic disease, women’s health and more! With new interactive sessions
such as a reverse pitch opportunity, technology showcase, poster session and
guided networking. This unmissable event provided the opportunity to transform
your drug development pipelines and meet like-minded individuals to help you
along the way.

QUICK DOWNLOAD

FIND OUT MORE


2024'S WORLD-CLASS SPEAKER FACULTY INCLUDED

ANA MONTALBAN-ARQUES

Chief Executive Officer

Recolony



JOHAN E.T. VAN HYLCKAMA VLIEG

CSO

Freya Biosciences ApS



MARIA LLUCH SENAR

Founder & Chief Scientific Officer

Pulmobiotics



RAFIK FELLAGUE-CHEBRA

Executive Global Group Medical Director

Novartis AG



STAFFAN STRÖMBERG

Chief Executive Officer

Infant Bacterial Therapeutics AB



YEMI ADESOKAN

Chief Executive & Scientific Officer

Gnubiotics Sciences



VIEW FULL SPEAKER LIST


IN 2024 WE COVERED:

Unearth more dedicated sessions across oncology research to reveal further MoA
understandings from advanced melanoma, NSC lung cancer, breast cancer and
epithelial cancers with Microbiotica, Pulmobiotics, Gnubiotics and Recolony

Engage in our exclusive reverse pitch opportunity with our investor panel to
find out exactly what it takes to secure continued investment and uncover your
competitive advantage for approaching investors

Gain clarity on European regulatory guidance for approval of therapies with
late-stage microbiome leaders sharing exactly what interactions they’ve had EMA
and FDA. We dig into novel regulatory questions around engineered microbes and
the use of artificial intelligence


ATTENDEE TESTIMONIALS

"In a field with many conferences of varying quality, the Microbiome Drug
Development Summit consistently delivers substantive and compelling
conversations and a collaborative vibe"

Celcius Therapeutics

"We need to combine our efforts to accelerate the knowledge and translation into
the clinic, and the Microbiome Movement is offering exactly what we are
needing."

Institute Gustave Roussy


OUR 2024 PARTNERS

Lead Partner



Expertise Partners




Program Partner



Innovation Partner




Exhibition Partners



Event Partner




EVENTS IN THE SERIES



BACK TO THE TOP


OUR CONTACT DETAILS

Phone
UK: +44 (0)20 3141 8700

Email
info@hansonwade.com


JOIN OUR TEAM

We are always looking for ambitious people to join our team. You'll have
opportunities to learn quickly, advance your career, and to meaningfully impact
our customers and our business.

Click here to learn about careers.


ABOUT US

Hanson Wade specializes in scientific research across a comprehensive range of
distinctive R&D areas. We deliver insight and connections to facilitate safe and
effective drug development for more personalized and targeted patient
populations.


EXPLORE OUR PRODUCTS

Conferences Beacon Searchlight Intelligence


SEARCH

Search


ORGANIZED BY



Terms & Conditions

Privacy Policy

A Hanson Wade Group Company



© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade
Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.

We use cookies to ensure that we give you the best experience on our website. If
you continue to use this site we will assume that you are happy with it.Ok